You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2024

CLINICAL TRIALS PROFILE FOR RIST4721


✉ Email this page to a colleague

« Back to Dashboard


Clinical Trials for RIST4721

Trial ID Title Status Sponsor Phase Summary
NCT03988335 ↗ A Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP) Completed Aristea Therapeutics, Inc. Phase 2 A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study to Evaluate the Efficacy and Safety of RIST4721 in Subjects with Palmoplantar Pustulosis
NCT04105959 ↗ A Study to Investigate the Effects of RIST4721 on the Inflammatory Response in Healthy Male Subjects Using a Blister Model Completed Aristea Therapeutics, Inc. Phase 1 A Randomised, Single-Blind, Placebo-Controlled, Crossover Study to Investigate the Effects of RIST4721, a Novel CXCR2 Inhibitor, on the Inflammatory Response in Healthy Male Subjects Using a Standardized Blister Model
NCT05023811 ↗ A Study of the ADME of [14C]RIST4721 in Healthy Male Subjects Recruiting Aristea Therapeutics, Inc. Phase 1 A Phase I, Open-label Study of Absorption-Distribution-Metabolism-Excretion (ADME) of [14C]RIST4721 Following a Single Oral Dose to Healthy Male Subjects
NCT05194839 ↗ A Phase 2b Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP) Recruiting Aristea Therapeutics, Inc. Phase 2 A Randomized, Double-blind, Placebo-controlled, Dose Ranging Phase 2 Study to Evaluate the Efficacy and Safety of RIST4721 in Subjects with Palmoplantar Pustulosis
NCT05348681 ↗ A Study to Evaluate RIST4721 in Hidradenitis Suppurativa (HS) Not yet recruiting Aristea Therapeutics, Inc. Phase 2 A Randomized, Double-blinded, Placebo-controlled, Phase 2a Study to Evaluate the Efficacy and Safety of RIST4721 in Subjects with Hidradenitis Suppurativa
>Trial ID >Title >Status >Phase >Summary

Clinical Trial Conditions for RIST4721

Condition Name

Condition Name
Intervention Trials
Palmoplantar Pustulosis 2
ADME 1
Familial Mediterranean Fever 1
Healthy 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH
Intervention Trials
Psoriasis 2
Hidradenitis Suppurativa 1
Hidradenitis 1
Blister 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for RIST4721

Trials by Country

Trials by Country
Location Trials
United States 8
Canada 5
United Kingdom 2
Germany 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State
Location Trials
Florida 2
New Hampshire 1
Nebraska 1
Indiana 1
California 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for RIST4721

Clinical Trial Phase

Clinical Trial Phase
Clinical Trial Phase Trials
Phase 2 4
Phase 1 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status
Clinical Trial Phase Trials
Completed 2
Not yet recruiting 2
Recruiting 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for RIST4721

Sponsor Name

Sponsor Name
Sponsor Trials
Aristea Therapeutics, Inc. 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type
Sponsor Trials
Industry 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.